Vimian Group AB (publ) (VIMGF)
OTCMKTS
· Delayed Price · Currency is USD
3.990
0.00 (0.00%)
At close: Jun 23, 2025
Vimian Group AB Market Cap
Vimian Group AB has a market cap or net worth of $2.20 billion as of July 1, 2025. Its market cap has increased by 27.87% in one year.
Market Cap
2.20B
Enterprise Value
2.40B
Revenue
422.61M
Ranking
n/a
PE Ratio
105.64
Stock Price
$3.99
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 2.20B, a decrease of -39.55%. That is a compound annual growth rate of -11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.18B | 15.80% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 759.65M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 442.61M |
| American Oncology Network | 433.75M |
| Northwest Biotherapeutics | 349.23M |